Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Interventional Cardiology Devices Market

May 2022

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

Mercado de dispositivos de cardiología intervencionista por producto (catéteres, dispositivos de modificación de la placa, dispositivos cardíacos estructurales, stents de angioplastia, balones de angioplastia, dispositivos de alternancia del flujo hemodinámico, otros dispositivos), por usuario final (hospitales, centros quirúrgicos ambulatorios, otros) y región (Norteamérica, Europa, Asia Pacífico, Sudamérica, Oriente Medio y África), tendencias globales y pronóstico de 2022 a 2029

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Descripción general del mercado de dispositivos de cardiología intervencionista


Se espera que el mercado mundial de dispositivos de cardiología intervencionista crezca a una tasa anual compuesta del 9,15 % entre 2022 y 2029. Se espera que alcance más de 29 720 millones de dólares en 2029, frente a los 13 800 millones de dólares de 2020.

La demanda de servicios sanitarios ha aumentado drásticamente en los últimos años a medida que la población mundial ha crecido. Además, debido al crecimiento de la población de edad avanzada, el número de pacientes que padecen trastornos cardiológicos y vasculares ha aumentado continuamente. Como resultado, ha aumentado la demanda de dispositivos utilizados en el tratamiento de enfermedades cardiológicas y vasculares. La cardiología intervencionista y los dispositivos vasculares periféricos también se pueden utilizar para tratar una amplia gama de problemas cardíacos y arteriales. Además, las mejoras tecnológicas han impulsado la cuota de mercado de la cardiología intervencionista y los dispositivos vasculares periféricos. Además, el rápido desarrollo del negocio sanitario en las naciones emergentes tiene un impacto beneficioso en el crecimiento de los mercados de cardiología intervencionista y dispositivos vasculares periféricos.


















































ATRIBUTODETALLES
Periodo de estudio2020-2029
Año base2021
Año estimado2022
Año pronosticado2022-2029
Periodo histórico2018-2020
UnidadValor (miles de millones de USD), (Miles de unidades)
SegmentaciónPor producto, por usuario final, por región
Por producto

  •  Catéteres

  • Dispositivos de modificación de plagas

  • Dispositivos cardíacos estructurales

  •  Stents de angioplastia

  • Balones de angioplastia

  •   Dispositivos de alternancia del flujo hemodinámico

  •  Otros dispositivos


Por el usuario final

  • Hospitales

  • Centros de cirugía ambulatoria

  • Otros


Por región

  • Asia Pacífico

  • América del norte

  • Ministerio de Asuntos Exteriores

  • Sudamerica

  • Europa



La enfermedad de las arterias coronarias (CAD) es el tipo de enfermedad cardíaca más frecuente en los Estados Unidos, matando a 365,914 personas en 2017, según los Centros para el Control y la Prevención de Enfermedades (CDC). Según los CDC, casi 18,2 millones de personas en los Estados Unidos mayores de 20 años se ven afectadas por CAD. Según la British Heart Foundation, 2,3 millones de personas en el Reino Unido tenían enfermedad de las arterias coronarias en junio de 2020. Las enfermedades cardíacas y circulatorias matan a 170.000 personas en el Reino Unido cada año. Se prevé que la necesidad de dispositivos de cardiología intervencionista aumente en los próximos años debido a una población de pacientes tan grande y una alta tasa de mortalidad. La necesidad de equipos de cardiología intervencionista también se ve impulsada por factores de riesgo como la diabetes y la hipertensión. Los pacientes con diabetes tienen más probabilidades de tener problemas de salud adicionales que aumentan su riesgo de enfermedad cardíaca coronaria. Los niveles altos de azúcar en sangre pueden dañar las arterias sanguíneas que regulan el corazón con el tiempo. Según la Federación Internacional de Diabetes (FID), se prevé que el número de diabéticos en todo el mundo aumente de 463 millones en 2019 a 700 millones en 2045. Cada año, 1,5 millones de estadounidenses en los Estados Unidos son diagnosticados con diabetes [fuente: Asociación Estadounidense de Diabetes (ADA)]. El aumento de la población de edad avanzada es en parte responsable del aumento de la prevalencia de la diabetes; se estima que el 25% de todas las personas geriátricas en los Estados Unidos tienen diabetes.


En el campo de la cardiología intervencionista, India, China y Brasil son mercados en gran medida inexplorados. La alta prevalencia de diabetes y la gran población de ancianos en estos y otros países en ascenso brindan perspectivas de desarrollo considerables para el equipo de cardiología intervencionista. Además, el ingreso disponible en India aumentó a 2,937.0 mil millones en 2019 desde 2,818.0 mil millones en 2018. Además, a medida que aumenta la conciencia de la salud en las naciones mencionadas anteriormente, es probable que aumente la demanda de modalidades de tratamiento sofisticadas, como la cardiología intervencionista.




[título id="attachment_9520" align="alignleft" width="870"]Interventional Cardiology Devices Market | Exactitude Consultancy
Mercado de dispositivos de cardiología intervencionista | Exactitude Consultancy
[/subtítulo]

Frequently Asked Questions

• What is the worth of the global Interventional Cardiology Devices market?

The Interventional Cardiology Devices market size had crossed USD 1.9 billion in 2020 and will observe a CAGR of more than % up to 2029 driven by the rising technological advancements.

• What is the size of the North America Interventional Cardiology Devices industry?

North America held more than 39% of the Interventional Cardiology Devices market revenue share in 2021 and will witness expansion. The presence of advanced healthcare infrastructure, favourable government product development initiatives, and high patient awareness levels, combined with relatively high healthcare expenditures in the region, are some of the major drivers for the interventional cardiology devices market to grow in the coming years. North America has a high rate of premium-priced interventional cardiology equipment consumption, and it is the area that can accommodate a high rate of medical device innovation, thereby dominating the market.

• What are the drivers, restraints and opportunities for the Interventional Cardiology Devices market, globally?

The rising prevalence of coronary artery disease is a driving force for the interventional cardiology devices market. One of the greatest opportunities is the emerging markets for interventional cardiology like India and China. Due to an aging population, the number of patients suffering from heart diseases is growing significantly throughout the world, thus increasing the demand for Interventional cardiology devices.

• Which are the top companies to hold the market share in the Interventional Cardiology Devices market?

Medtronic, Boston Scientific Corporation, Abbott, Edward LiveScience’s Corporation, Cardinal Health, iVascular, B. Braun Melsungen, Terumo Corporation, Biosensors International Group, BIOTRONIK SE & Co. KG are the key players in the Interventional Cardiology Market.

• Which is the largest regional market for Interventional Cardiology Devices market?

North America, followed by Europe, was the largest regional component of the entire market in 2020. The high incidence of chronic illnesses, expanding geriatric population, increasing use of minimally invasive treatments, and the presence of significant companies in the region all contribute to the region's big market share.

• Which region is expected to experience the greatest CAGR during the forecast period?

In the field of interventional cardiology, India, China, and Brazil are largely untouched markets. The high prevalence of diabetes and the big elderly population in these and other rising nations provide considerable development prospects for interventional cardiology equipment. According to the IDF, 77.0 million individuals in India had diabetes in 2019, with a projected increase to 101.0 million by 2030. Similarly, China's diabetes population is expected to increase to 140.5 million by 2030, up from 116.4 million in 2019.

Interventional Cardiology Devices Market Segment Analysis

The interventional cardiology devices market is divided on the basis of product into catheters, plague modification devices, structural heart devices, angioplasty stents, angioplasty balloons, hemodynamic flow alternation devices and other devices. Furthermore, on the basis of end users it can be divided into hospitals, ambulatory surgical centers and others.

The Angiography Catheters segment has the biggest market share among catheters. This is owing to an increase in the number of instances of coronary artery diseases and the benefits of early detection. Hemodynamic Flow Alteration Devices include Embolic Protection Devices, which are a subset of Hemodynamic Flow Alteration Devices. This is owing to the Embolic Protection Device's capacity to catch embolic debris without halting continuous blood flow, which gives it an edge over the Chronic Total Occlusion Device. The hemodynamic flow alteration devices market has been divided into two types: embolic protection devices and chronic complete occlusion devices, based on kind. In 2019, the embolic protection devices segment accounted for the largest proportion of the hemodynamic flow alteration devices market, followed by the hemodynamic flow alteration devices sector. This can be linked to embolic protection devices' benefits over chronic complete occlusion devices, such as their capacity to catch embolic debris while maintaining continuous blood flow. Furthermore, the number of interventional procedures for the treatment of coronary artery disease is growing.

[caption id="attachment_9521" align="alignleft" width="680"]Interventional Cardiology Devices Market | Exactitude Consultancy
Interventional Cardiology Devices Market | Exactitude Consultancy
[/caption]

Interventional Cardiology Devices Market Players

Medtronic, Boston Scientific Corporation, Abbott, Edward LiveScience’s Corporation, Cardinal Health, iVascular, B. Braun Melsungen, Terumo Corporation, Biosensors International Group, BIOTRONIK SE & Co. KG are the key players in the Interventional Cardiology Market.
  • Edward Lifesciences Corporation (US) got Chinese regulatory clearance in 2020 for the SAPIEN 3 Transcatheter Heart Valve, which is used to treat patients with severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery.
  • The Next-Generation Evolut PRO+ TAVR System from Medtronic (US) was approved by the US FDA in 2019 for the treatment of symptomatic severe aortic stenosis in patients.
  • The MitraClip Heart Valve Repair Device was approved by the US FDA in 2019 to treat mitral regurgitation.

Who Should Buy? Or Key Stakeholders

  • Hospitals and Clinics
  • Individual medical practitioners
  • Patients
  • Doctors and health workers
  • IT companies
  • Pharmaceutical companies
  • Others

Interventional Cardiology Devices Market Regional Analysis

The Interventional Cardiology Devices market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

  • North America: includes the US, Canada, Mexico
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • South America: includes Brazil, Argentina and Rest of South America
  • Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
[caption id="attachment_9523" align="alignleft" width="680"]Interventional Cardiology Devices Market | Exactitude Consultancy
Interventional Cardiology Devices Market | Exactitude Consultancy
[/caption]

Key Market Segments: Interventional Cardiology Devices Market

Interventional Cardiology Devices Market by Product, 2020-2029, (USD Million), (Thousand Units)
  • Catheters
  • Plague Modification Devices
  • Structural Heart Devices
  • Angioplasty Stents
  • Angioplasty Balloons
  • Hemodynamic Flow Alternation Devices
  • Other Devices
Interventional Cardiology Devices Market by End User, 2020-2029, (USD Million), (Thousand Units)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Interventional Cardiology Devices Market by Region, 2020-2029, (USD Million), (Thousand Units)
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East And Africa
Important countries in all regions are covered.

Key Question Answered

  • What is the current size of the Interventional Cardiology Devices market?
  • What are the key factors influencing the growth of Interventional Cardiology Devices?
  • What are the major end use industries for Interventional Cardiology Devices?
  • Who are the major key players in the Interventional Cardiology Devices market?
  • Which region will provide more business opportunities for Interventional Cardiology Devices in future?
  • Which segment holds the maximum share of the Interventional Cardiology Devices market?

  1. Introducción

    1. Definición de mercado

    2. Segmentación del mercado

    3. Cronología de la investigación

    4. Supuestos y limitaciones



  2. Metodología de la investigación

    1. Minería de datos

      1. Investigación secundaria

      2. Investigación primaria

      3. Asesoramiento de expertos en la materia



    2. Controles de calidad

      1. Revisión final



    3. Triangulación de datos

      1. Enfoque de abajo hacia arriba

      2. Enfoque de arriba hacia abajo

      3. Flujo de investigación



    4. Fuentes de datos



  3. Resumen ejecutivo

  4. Descripción general del mercado

    1. Perspectivas del mercado mundial de dispositivos de cardiología intervencionista

      1. Factores impulsores del mercado

      2. Restricciones del mercado

      3. Oportunidades de mercado



    2. Impacto de Covid-19 en el mercado de dispositivos de cardiología intervencionista

    3. Modelo de las cinco fuerzas de Porter

      1. Amenaza de nuevos participantes

      2. Amenaza de sustitutos

      3. Poder de negociación de los proveedores

      4. Poder de negociación de los clientes

      5. Grado de competencia



    4. Análisis de la cadena de valor de la industria



  5. Mercado mundial de dispositivos de cardiología intervencionista por producto

    1. Catéteres

    2. Dispositivos de modificación de plagas

    3. Structural Heart Devices

    4. Angioplasty Stents

    5. Angioplasty Balloons

    6. Hemodynamic Flow Alternation Devices

    7. Other Devices



  6. Global Interventional Cardiology Devices Market by End User

    1. Hospitals

    2. Ambulatory Surgical Centers

    3. Others



  7. Global Interventional Cardiology Devices Market by Region

    1. North America

      1. US

      2. Canada

      3. Mexico



    2. South America

      1. Brazil

      2. Argentina

      3. Colombia

      4. Rest Of South America



    3. Europe

      1. Germany

      2. UK

      3. France

      4. Italy

      5. Spain

      6. Russia

      7. Rest Of Europe



    4. Asia Pacific

      1. India

      2. China

      3. Japan

      4. South Korea

      5. Australia

      6. South-East Asia

      7. Rest Of Asia Pacific



    5. Middle East and Africa

      1. UAE

      2. Saudi Arabia

      3. South Africa

      4. Rest Of Middle East and Africa





  8. Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)



    1. Medtronic

    2. Boston Scientific Corporation

    3. Abbott

    4. Edward LiveScience’s Corporation

    5. Cardinal Health

    6. iVascular

    7. Braun Melsungen

    8. Terumo Corporation

    9. Biosensors International Group

    10. BIOTRONIK SE & Co. KG




*The Company List Is Indicative

 

LIST OF TABLES


TABLE 1                GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 2                GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 3                GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 4                GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 5                GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 6                GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY REGION (THOUSAND UNITS) 2020-2029

TABLE 7                US INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 8                US INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 9                US INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 10              US INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 11              CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 12              CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 13              CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 14              CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 15              MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 16              MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 17              MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 18              MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 19              BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 20              BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 21              BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 22              BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 23              ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 24              ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 25              ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 26              ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 27              COLOMBIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 28              COLOMBIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 29              COLOMBIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 30              COLOMBIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 31              REST OF SOUTH AMERICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 32              REST OF SOUTH AMERICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 33              REST OF SOUTH AMERICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 34              REST OF SOUTH AMERICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 35              INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 36              INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 37              INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 38              INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 39              CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 40              CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 41              CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 42              CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 43              JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 44              JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 45              JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 46              JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 47              SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 48              SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 49              SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 50              SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 51              AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 52              AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 53              AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 54              AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 55              SOUTH-EAST ASIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 56              SOUTH-EAST ASIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 57              SOUTH-EAST ASIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 58              SOUTH-EAST ASIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 59              REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 60              REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 61              REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 62              REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 63              GERMANY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 64              GERMANY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 65              GERMANY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 66              GERMANY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 67              UK INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 68              UK INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 69              UK INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 70              UK INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 71              FRANCE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 72              FRANCE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 73              FRANCE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 74              FRANCE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 75              ITALY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 76              ITALY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 77              ITALY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 78              ITALY INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 79              SPAIN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 80              SPAIN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 81              SPAIN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 82              SPAIN INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 83              RUSSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 84              RUSSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 85              RUSSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 86              RUSSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 87              REST OF EUROPE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 88              REST OF EUROPE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 89              REST OF EUROPE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 90              REST OF EUROPE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 91              UAE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 92              UAE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 93              UAE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 94              UAE INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 95              SAUDI ARABIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 96              SAUDI ARABIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 97              SAUDI ARABIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 98              SAUDI ARABIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 99              SOUTH AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 100            SOUTH AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 101            SOUTH AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 102            SOUTH AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

TABLE 103            REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 104            REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029

TABLE 105            REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 106            REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END USER (THOUSAND UNITS) 2020-2029

 

 

LIST OF FIGURES


 

FIGURE 1        MARKET DYNAMICS

FIGURE 2        MARKET SEGMENTATION

FIGURE 3        REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4        DATA TRIANGULATION

FIGURE 5        BOTTOM-UP APPROACH

FIGURE 6        TOP-DOWN APPROACH

FIGURE 7        RESEARCH FLOW

FIGURE 8        GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 9        GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY END-USER INDUSTRY, USD MILLION, 2020-2029

FIGURE 10     GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 11           PORTER’S FIVE FORCES MODEL

FIGURE 12           NORTH AMERICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT

FIGURE 13           EUROPE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT

FIGURE 14           ASIA PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT

FIGURE 15           SOUTH AMERICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT

FIGURE 16           MIDDLE EAST & AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT

FIGURE 17           MEDTRONIC: COMPANY SNAPSHOT

FIGURE 18           BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

FIGURE 19           ABBOTT: COMPANY SNAPSHOT

FIGURE 20           EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT

FIGURE 21           CARDINAL HEALTH: COMPANY SNAPSHOT

FIGURE 22           IVASCULAR: COMPANY SNAPSHOT

FIGURE 23           B. BRAUN MELSUNGEN: COMPANY SNAPSHOT

FIGURE 24           TERUMO CORPORATION: COMPANY SNAPSHOT

FIGURE 25           BIOSENSORS INTERNATIONAL GROUP: COMPANY SNAPSHOT

FIGURE 26           BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
7247

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.